Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04281979 · ClinicalTrials.gov registry record · NA

Effects of a Specific Substance in Smokers

A NA study of Smoking, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04281979 is a NA study of Smoking that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 60 participants, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04281979, a NA study of Smoking, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Although rates of cigarette use are declining, the proportion of nondaily smokers is rising, particularly among young adults. Among young adults, nondaily smoking is associated with negative health consequences and, for some, may lead to the establishment of life-long smoking patterns. The goal of this project is to understand the behavioral, psychological and neurobiological factors that contribute to cigarette use in nondaily smokers to aid the development of tailored evidence-based interventions.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Study Agent

Study Locations (1)

Oregon

  • Oregon Health and Science University - Portland

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2020-02-25
Est. Completion 2025-12-31
Phase NA

What the Registry Record Tells You About NCT04281979

The ClinicalTrials.gov registry entry for NCT04281979 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (87% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04281979 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT04281979 about?

NCT04281979 is a clinical study titled "Effects of a Specific Substance in Smokers". Although rates of cigarette use are declining, the proportion of nondaily smokers is rising, particularly among young adults. Among young adults, nondaily smoking is associated with negative health consequences and, for some, may lead to the establishment of life-long smoking patterns. The goal of t...

What is the current status of trial NCT04281979?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2020-02-25. Estimated completion is 2025-12-31.

What conditions does trial NCT04281979 study?

This clinical trial studies the following conditions: Smoking.

What interventions are being tested in trial NCT04281979?

The interventions under investigation include: Placebo (DRUG), Study Agent (DRUG).

Who is sponsoring clinical trial NCT04281979?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04281979 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.